LadRx Financials

LADX

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2025 Currency USD FYE December

Financial Health Signals

Piotroski F-Score Weak

2/9

LadRx passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.

Earnings Quality Low Quality

0.82x

For every $1 of reported earnings, LadRx generates $0.82 in operating cash flow (-$1.3M OCF vs -$1.6M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

This page shows LadRx (LADX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

N/A

EBITDA

-$3.6M

YoY+5.1%

LadRx's EBITDA was -$3.6M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 5.1% from the prior year.

Free Cash Flow

N/A

Net Income

-$1.6M

YoY-497.0%

LadRx reported -$1.6M in net income in fiscal year 2024. This represents a decrease of 497.0% from the prior year.

EPS (Diluted)

$-3.21

YoY-572.1%

LadRx earned $-3.21 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 572.1% from the prior year.

Cash & Debt

$760K

YoY-63.3%

5Y CAGR-45.7%

10Y CAGR-31.3%

LadRx held $760K in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

495,092

YoY+0.0%

LadRx had 495,092 shares outstanding in fiscal year 2024. This represents an increase of 0.0% from the prior year.

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

R&D Spending

$773K

YoY+176.5%

5Y CAGR+13.9%

10Y CAGR-32.0%

LadRx invested $773K in research and development in fiscal year 2024. This represents an increase of 176.5% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

LADX Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$773K+176.5%	$279K	N/A	N/A	$800K+98.4%	$403K
SG&A Expenses	$2.8M-19.5%	$3.5M-22.3%	$4.5M-23.8%	$6.0M-0.6%	$6.0M-19.3%	$7.4M
Operating Income	-$3.6M+5.2%	-$3.8M+16.2%	-$4.6M+62.2%	-$12.1M-76.8%	-$6.8M+13.1%	-$7.9M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	$8000.0%	$800
Net Income	-$1.6M-497.0%	$400K+109.5%	-$4.2M+68.1%	-$13.2M-96.6%	-$6.7M+6.5%	-$7.2M
EPS (Diluted)	$-3.21-572.1%	$0.68+718.2%	$-0.11	N/A	N/A	N/A

Metric	Q1'25	Q1'24	Q3'24	Q4'23	Q3'23	Q4'22	Q3'22	Q4'21
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$29K-4.9%	$30K+578.8%	$4K	N/A	$15K	N/A	N/A	N/A
SG&A Expenses	$691K-13.8%	$802K-2.6%	$823K	N/A	$826K	N/A	$1.2M	N/A
Operating Income	-$720K+13.5%	-$832K-0.5%	-$828K	N/A	-$840K	N/A	-$1.2M	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$719K-485.2%	$187K+122.6%	-$825K	N/A	-$816K	N/A	-$1.2M	N/A
EPS (Diluted)	$-1.45-481.6%	$0.38+122.8%	$-1.67	N/A	$-1.65	N/A	$-2.78	N/A

LADX Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$840K-63.6%	$2.3M+2.7%	$2.2M-74.3%	$8.7M-27.6%	$12.1M-30.1%	$17.3M
Current Assets	$837K-63.0%	$2.3M+12.9%	$2.0M-75.8%	$8.3M-27.5%	$11.4M-33.6%	$17.2M
Cash & Equivalents	$760K-63.3%	$2.1M+50.6%	$1.4M-79.7%	$6.8M-32.3%	$10.0M-38.0%	$16.1M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.3M+2.7%	$2.2M-38.3%	$3.6M-55.3%	$8.0M+150.0%	$3.2M+55.6%	$2.1M
Current Liabilities	$2.3M+2.7%	$2.2M+0.6%	$2.2M-41.4%	$3.7M+34.6%	$2.8M+35.3%	$2.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$1.4M-1422.2%	$107K+108.1%	-$1.3M-274.9%	$754K-91.5%	$8.9M-41.7%	$15.2M
Retained Earnings	-$490.1M-0.3%	-$488.5M+0.1%	-$488.8M-1.0%	-$484.1M-2.8%	-$470.7M-1.4%	-$464.0M

Metric	Q1'25	Q1'24	Q3'24	Q4'23	Q3'23	Q4'22	Q3'22	Q4'21
Total Assets	$260K-69.0%	$840K+1028.8%	$74K-96.8%	$2.3M-24.7%	$3.1M+36.4%	$2.2M-33.5%	$3.4M-61.3%	$8.7M
Current Assets	$258K-69.1%	$837K+1082.0%	$71K-96.9%	$2.3M-23.8%	$3.0M+48.2%	$2.0M-35.1%	$3.1M-62.7%	$8.3M
Cash & Equivalents	$207K-72.8%	$760K+1226.9%	$57K-97.2%	$2.1M-29.4%	$2.9M+113.3%	$1.4M-54.4%	$3.0M-55.5%	$6.8M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.4M+6.0%	$2.3M+23.5%	$1.8M-16.9%	$2.2M+4.8%	$2.1M-41.1%	$3.6M-3.3%	$3.7M-53.8%	$8.0M
Current Liabilities	$2.4M+6.0%	$2.3M+23.5%	$1.8M-16.9%	$2.2M+4.8%	$2.1M-4.0%	$2.2M-3.2%	$2.3M-39.5%	$3.7M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$2.1M-50.4%	-$1.4M+19.1%	-$1.8M-1734.3%	$107K-88.9%	$965K+173.2%	-$1.3M-328.9%	-$307K-140.8%	$754K
Retained Earnings	-$490.8M-0.1%	-$490.1M+0.1%	-$490.4M-0.4%	-$488.5M-0.2%	-$487.6M+0.2%	-$488.8M-0.2%	-$487.8M-0.8%	-$484.1M

LADX Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	-$1.3M-229.2%	$1.0M+121.0%	-$4.8M+60.7%	-$12.3M-100.5%	-$6.1M-7.4%	-$5.7M
Capital Expenditures	N/A	N/A	$766-89.1%	$7K-73.0%	$26K+5.0%	$25K
Free Cash Flow	N/A	N/A	-$4.8M+60.8%	-$12.3M-99.7%	-$6.2M-7.4%	-$5.7M
Investing Cash Flow	N/A	N/A	-$766+89.1%	-$7K+73.0%	-$26K-105.4%	$475K
Financing Cash Flow	N/A	-$319K+43.2%	-$561K-106.2%	$9.1M+23187.5%	$39K	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'25	Q1'24	Q3'24	Q4'23	Q3'23	Q4'22	Q3'22	Q4'21
Operating Cash Flow	-$553K-178.7%	$702K+192.5%	-$759K+12.0%	-$863K-28.9%	-$670K+57.4%	-$1.6M-55.3%	-$1.0M+89.4%	-$9.5M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	$0	$0	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	-$1.6M-55.3%	-$1.0M	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	$0	$0	N/A
Financing Cash Flow	N/A	N/A	N/A	$0	$0+100.0%	-$69K+18.1%	-$84K+51.1%	-$172K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

LADX Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	373.0%	N/A	N/A	N/A	N/A
Return on Assets	-189.4%-206.7pp	17.3%+204.3pp	-187.0%-36.0pp	-151.0%-95.4pp	-55.6%-14.0pp	-41.5%
Current Ratio	0.37-0.7	1.03+0.1	0.92-1.3	2.22-1.9	4.12-4.3	8.39
Debt-to-Equity	-1.59-22.1	20.50+23.2	-2.70-13.3	10.58+10.2	0.36+0.2	0.13
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'25	Q1'24	Q3'24	Q4'23	Q3'23	Q4'22	Q3'22	Q4'21
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	54.1%	N/A	N/A	176.8%	N/A	N/A	N/A
Return on Assets	-276.6%-285.0pp	8.4%+1117.0pp	-1108.6%	N/A	-26.6%	N/A	-34.5%	N/A
Current Ratio	0.11-0.3	0.37+0.3	0.04-1.0	1.03-0.4	1.41+0.5	0.92-0.5	1.37-0.9	2.22
Debt-to-Equity	-1.12+0.5	-1.59-0.5	-1.04-21.5	20.50+18.3	2.18+4.9	-2.70+9.3	-12.00-22.6	10.58
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$1.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.37), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Lobe Sciences LOBEF

$696K

AIBotics AIBT

$576K

Therapeutic Solutions Intl Inc TSOI

$512K

Bio-Path Hldgs Inc BPTH

$4.7M

Emmaus Life Scie EMMA

$696K

Frequently Asked Questions

Is LadRx profitable?

No, LadRx (LADX) reported a net income of -$1.6M in fiscal year 2024.

What is LadRx's earnings per share (EPS)?

LadRx (LADX) reported diluted earnings per share of $-3.21 for fiscal year 2024. This represents a -572.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is LadRx's EBITDA?

LadRx (LADX) had EBITDA of -$3.6M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is LadRx's operating cash flow?

LadRx (LADX) generated -$1.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are LadRx's total assets?

LadRx (LADX) had $840K in total assets as of fiscal year 2024, including both current and long-term assets.

How much does LadRx spend on research and development?

LadRx (LADX) invested $773K in research and development during fiscal year 2024.

How many shares does LadRx have outstanding?

LadRx (LADX) had 495,092 shares outstanding as of fiscal year 2024.

What is LadRx's current ratio?

LadRx (LADX) had a current ratio of 0.37 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

What is LadRx's debt-to-equity ratio?

LadRx (LADX) had a debt-to-equity ratio of -1.59 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is LadRx's return on assets (ROA)?

LadRx (LADX) had a return on assets of -189.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is LadRx's cash runway?

Based on fiscal year 2024 data, LadRx (LADX) had $760K in cash against an annual operating cash burn of $1.3M. This gives an estimated cash runway of approximately 7 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is LadRx's debt-to-equity ratio negative or unusual?

LadRx (LADX) has negative shareholder equity of -$1.4M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is LadRx's Piotroski F-Score?

LadRx (LADX) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are LadRx's earnings high quality?

LadRx (LADX) has an earnings quality ratio of 0.82x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.